APTOSE BIOSCIENCES INC FILES PROSPECTUS RELATED TO RESALE OF UP TO 12 MILLION COMMON SHARES BY SELLING STOCKHOLDERS- SEC FILING
Source text: [ID:n0001193125-25-026207]
Further company coverage: APS.TO
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.